By Colin Kellaher 



  Medtronic PLC on Wednesday said it agreed to buy French implant-technologies company Medicrea International S.A. for about 135.4 million euros ($154.4 million) in a deal that bolsters its spine-surgery business. 


  The Dublin-based medical-technology company said it will pay EUR7.00 a share in cash for Medicrea, a 21.5% premium to Tuesday's closing price of EUR5.76. 


  Medtronic said the acquisition will make it the first company to offer an integrated spinal-surgery solution that includes artificial intelligence-driven surgical planning, personalized spinal implants and robotic-assisted surgery. 


  Medtronic said it expects to complete the acquisition by the end of 2020, adding that the deal will be immaterial to its adjusted per-share earnings in the first two fiscal years before turning accretive in fiscal 2023. 


  Paris-listed shares of Medicrea were recently up 20.5% to EUR6.94. 


  Write to Colin Kellaher at colin.kellaher@wsj.com